Jakarta, July 11 -- Indonesia's Food and Drug Supervisory Agency (BPOM) said adaptive biotechnology and pharmaceutical regulations are essential to speed innovation while ensuring public safety, as the global advanced therapy market is expected to more than double by 2031.

BPOM Head Taruna Ikrar said the global market for Advanced Therapy Medicinal Products (ATMPs) is projected to grow from US$41.46 billion in 2026 to US$86.76 billion by 2031.

"The data shows ATMPs are expanding rapidly worldwide. This highlights the need for strong, adaptive regulations to protect public health while ensuring safe and efficient access to innovative therapies," Ikrar said on Saturday.

He said the trend underscores the need for closer integration of neu...